ConductScience.org, home

Paper42903397PubMed

Anticoagulants beyond coagulation: repurposing heparin to mitigate immunothrombosis and inflammatory cascades in sepsis.

Ren Y and 10 others. Front Pharmacol, 2026.

Cite this record

ConductScience Library. Anticoagulants beyond coagulation: repurposing heparin to mitigate immunothrombosis and inflammatory cascades in sepsis. Papers, record 42903397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anticoagulants beyond coagulation: repurposing heparin to mitigate immunothrombosis and inflammatory cascades in sepsis.
Journal
Front Pharmacol
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-23

Source PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ren YYanming
2Meng HHongqi
3Li BBeibei
4Wang YYuhao
5Gu LLulu
6Lv RRuyue
7Xue LLetian
8Xu LLi
9Zhang HHao
10Wang DDinghang
11Sun PPeng

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137221630The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.J Intensive Care2023https://conductscience.org/library/papers/37221630PubMed
238245889International Consensus Criteria for Pediatric Sepsis and Septic Shock.JAMA2024https://conductscience.org/library/papers/38245889PubMed
338302978Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.Cardiovasc Diabetol2024https://conductscience.org/library/papers/38302978PubMed
437958788Role of Neutrophil Extracellular Traps in Health and Disease Pathophysiology: Recent Insights and Advances.Int J Mol Sci2023https://conductscience.org/library/papers/37958788PubMed
528561234Point-of-Care Testing in Acute Hemorrhagic and Thrombotic States.Semin Thromb Hemost2017https://conductscience.org/library/papers/28561234PubMed
639905519"The NET effect": Neutrophil extracellular traps-a potential key component of the dysregulated host immune response in sepsis.Crit Care2025https://conductscience.org/library/papers/39905519PubMed
726632486Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems.Thromb Haemost2016https://conductscience.org/library/papers/26632486PubMed
839334845The Preventive and Therapeutic Effects of Acute and Severe Inflammatory Disorders with Heparin and Heparinoid.Biomolecules2024https://conductscience.org/library/papers/39334845PubMed
938197931ICU-acquired infections in immunocompromised patients.Intensive Care Med2024https://conductscience.org/library/papers/38197931PubMed
1039142741The burden and contemporary epidemiology of sepsis in children.Lancet Child Adolesc Health2024https://conductscience.org/library/papers/39142741PubMed
1137359014Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy.Front Med (Lausanne)2023https://conductscience.org/library/papers/37359014PubMed
1226261772Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums.World J Crit Care Med2015https://conductscience.org/library/papers/26261772PubMed
1341418999Damage-associated Molecular Patterns, Immunothrombosis, and Intravascular Inflammation in Sepsis: A Narrative Integrative Review.Semin Thromb Hemost2025https://conductscience.org/library/papers/41418999PubMed
1433587773Heparanase expression and activity are increased in platelets during clinical sepsis.J Thromb Haemost2021https://conductscience.org/library/papers/33587773PubMed
1534657233Unfractionated Heparin Attenuated Histone-Induced Pulmonary Syndecan-1 Degradation in Mice: a Preliminary Study on the Roles of Heparinase Pathway.Inflammation2022https://conductscience.org/library/papers/34657233PubMed
1635047524Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database.Front Med (Lausanne)2021https://conductscience.org/library/papers/35047524PubMed
1736802946Effect of Anticoagulant Versus Non-Anticoagulant Therapy on Mortality of Sepsis-Induced Disseminated Intravascular Coagulation: A Systematic Review and Meta-Analysis.Clin Appl Thromb Hemost2023https://conductscience.org/library/papers/36802946PubMed
1840904580Neutrophil extracellular traps in sepsis: trade-off between pros and cons.Burns Trauma2025https://conductscience.org/library/papers/40904580PubMed
1935690822Clinical applications of machine learning in the survival prediction and classification of sepsis: coagulation and heparin usage matter.J Transl Med2022https://conductscience.org/library/papers/35690822PubMed
2040221045Proteolytic neutralization of extracellular histones by neutrophil elastase is enhanced by heparin.J Thromb Haemost2025https://conductscience.org/library/papers/40221045PubMed

See all 102 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42903397

GET https://conductscience.org/api/papers/v1/42903397/references?page=2